BENNETT C FRANK
SEC CIK 1073387 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | Off. Level 14 | 60.1K | — | $23.38M | 48 | 2021-08-31 | 2026-08-31 |
Most active insiders at IONS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Monia Brett P | CEO, Dir | — | $30.35M |
| 2 | HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| 3 | BENNETT C FRANK | EVP, CSO | — | $16.71M |
| 4 | Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| 5 | O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| 6 | Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| 7 | Swayze Eric | EVP Research | — | $7.51M |
| 8 | LOSCALZO JOSEPH | Dir | — | $7.09M |
| 9 | KLEIN JOSEPH III | Dir | — | $6.00M |
| 10 | WENDER JOSEPH H | Dir | — | $5.44M |
Transactions 48
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 20:32 | 2026-08-31 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $51.31 | +110 | 60.1K | +0.2% | +$5,644 | |
| DT | 2026-07-09 19:26 | 2026-07-07 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $83.58 | -5,536 | 75.0K | -7% | -$462.7K |
| DTI | 2026-07-09 19:26 | 2026-07-07 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $0.00 | +15.0K | 15.0K | New | $0 |
| DTI | 2026-07-09 19:26 | 2026-07-07 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $85.46 | -15.0K | 0 | -100% | -$1.28M |
| DM | 2026-03-05 | 2026-03-03 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $53.73 | +65.1K | 165.6K | +65% | +$3.50M |
| DM | 2026-03-05 | 2026-03-03 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $79.23 | -85.1K | 80.6K | -51% | -$6.74M |
| 2026-03-03 | 2026-02-27 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $48.87 | +261 | 100.6K | +0.3% | +$12.8K | |
| A | 2026-02-13 | 2026-02-02 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | — | 0 | 100.3K | New | — |
| DM | 2026-02-04 | 2026-02-02 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $82.93 | -85.1K | 80.3K | -51% | -$7.06M |
| DM | 2026-02-04 | 2026-02-02 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $53.73 | +65.1K | 128.9K | +102% | +$3.50M |
| 2026-02-02 | 2026-01-29 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | A - Grant | $0.00 | +11.4K | 106.2K | +12% | $0 | |
| 2026-02-02 | 2026-01-30 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $82.95 | -5,885 | 100.3K | -6% | -$488.2K | |
| D | 2026-01-20 | 2026-01-16 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $75.15 | -8,977 | 94.8K | -9% | -$674.6K |
| D | 2026-01-20 | 2026-01-15 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +21.1K | 103.7K | +25% | $0 |
| 2025-09-09 | 2025-09-05 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $59.60 | -6,000 | 82.7K | -7% | -$357.6K | |
| DM | 2025-09-04 | 2025-09-02+ | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $59.14 | -38.9K | 101.6K | -28% | -$2.30M |
| DM | 2025-09-04 | 2025-09-03 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $55.44 | +33.9K | 88.7K | +62% | +$1.88M |
| 2025-09-03 | 2025-08-29 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $27.71 | +213 | 93.7K | +0.2% | +$5,902 | |
| D | 2025-08-20 | 2025-08-18 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $43.98 | -10.0K | 93.5K | -10% | -$439.8K |
| D | 2025-08-20 | 2025-08-18 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $32.60 | +10.0K | 103.5K | +11% | +$326.0K |
| 2025-03-04 | 2025-02-28 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $28.21 | +320 | 93.5K | +0.3% | +$9,027 | |
| 2025-02-03 | 2025-01-30 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | A - Grant | $0.00 | +3,607 | 94.5K | +4% | $0 | |
| 2025-02-03 | 2025-01-31 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $32.46 | -1,327 | 93.1K | -1% | -$43.1K | |
| D | 2025-01-17 | 2025-01-15 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +18.0K | 97.6K | +23% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $32.90 | -6,752 | 90.9K | -7% | -$222.1K |
| 2024-09-04 | 2024-08-30 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $38.64 | +177 | 79.6K | +0.2% | +$6,839 | |
| A | 2024-09-04 | 2024-02-02 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $49.52 | -1,885 | 79.0K | -2% | -$93.3K |
| 2024-03-04 | 2024-02-29 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | Off. Level 14 | J - Other | $34.43 | +383 | 79.5K | +0.5% | +$13.2K | |
| 2024-02-02 | 2024-02-02 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $49.52 | -1,853 | 79.1K | -2% | -$91.8K | |
| 2024-02-02 | 2024-02-01 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | A - Grant | $0.00 | +3,609 | 80.9K | +5% | $0 | |
| D | 2024-01-18 | 2024-01-16 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +18.3K | 84.1K | +28% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $50.42 | -6,745 | 77.3K | -8% | -$340.1K |
| DM | 2023-12-22 | 2023-12-20+ | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $49.39 | -22.6K | 65.8K | -26% | -$1.12M |
| DM | 2023-12-22 | 2023-12-20+ | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $47.34 | +22.6K | 81.9K | +38% | +$1.07M |
| DM | 2023-12-18 | 2023-12-14 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $47.34 | +22.6K | 79.8K | +40% | +$1.07M |
| DM | 2023-12-18 | 2023-12-14 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $49.58 | -22.6K | 65.8K | -26% | -$1.12M |
| 2023-09-29 | 2023-09-28 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $46.50 | -4,460 | 65.8K | -6% | -$207.4K | |
| 2023-09-05 | 2023-08-31 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | Off. Level 14 | J - Other | $30.56 | +180 | 70.2K | +0.3% | +$5,501 | |
| 2023-03-02 | 2023-02-28 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $30.52 | +383 | 70.0K | +0.5% | +$11.7K | |
| 2023-02-07 | 2023-02-03 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | A - Grant | $0.00 | +3,609 | 71.5K | +5% | $0 | |
| 2023-02-07 | 2023-02-06 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale | $40.57 | -1,813 | 69.7K | -3% | -$73.6K | |
| D | 2023-01-19 | 2023-01-17 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +19.4K | 74.8K | +35% | $0 |
| D | 2023-01-19 | 2023-01-18 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $38.89 | -6,978 | 67.9K | -9% | -$271.4K |
| 2022-09-01 | 2022-08-31 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $28.97 | +183 | 55.4K | +0.3% | +$5,302 | |
| 2022-03-02 | 2022-02-28 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $28.37 | +346 | 55.2K | +0.6% | +$9,816 | |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +18.8K | 61.6K | +44% | $0 |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | F - Tax | $30.12 | -6,726 | 54.9K | -11% | -$202.6K |
| 2021-09-02 | 2021-08-31 | IONS | IONIS PHARMACEUTICALS INC | BENNETT C FRANK | EVP, CSO | J - Other | $33.80 | +151 | 42.8K | +0.4% | +$5,104 |
Purchase Sale Sale after option exercise All abbreviations